Allogeneic stem cell transplantation
Allogeneic stem cell transplantation has been studied in 5 papers since 2016: 5 observational studies in people. The newest paper, Sep 4, 2021: “Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot study”.
5 papers study it1 findingUpdated
See all 5 papers on allogeneic stem cell transplantation
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“allogeneic transplant recipients (1.9-fold increase, p=0.0004)”
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 1 country
- Funders: National Cancer Institute and 2 more
- Humans5
What did studies of allogeneic stem cell transplantation find?
1Studies of allogeneic stem cell transplantation measured one outcome, p16INK4a.
p16INK4a
upin humans1
1 study
p16INK4a
upin humans1
Allogeneic stem cell transplantation is linked with higher p16INK4a in humans (1.9-fold increase, p=0.0004).
HumansT-cells6 months
Latest
Journal of Geriatric Oncology
Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot study
Cohort study of 50 peoplePopulations
Bone Marrow Transplantation
Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years)
Cohort study of 187 peopleMyelodysplastic syndrome
EBioMedicine
Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging
Cohort study of 63 peoplep16INK4a
Clinical Lymphoma, Myeloma & Leukemia
Myelodysplastic Syndromes in Adolescent Young Adults: One Institution's Experience
Cohort study of 1,897 peopleMyelodysplastic syndrome